Outcome prediction in adult core binding factor (CBF) acute myeloid leukemia (AML) with gene expression profiling: A Cancer and Leukemia Group B (CALGB) study

被引：5
|
作者：
Paschka, P.
Radmacher, M. D.
Marcucci, G.
Ruppert, A. S.
Vukosavljevic, T.
Whitman, S. P.
Mrozek, K.
Liu, C.
Larson, R. A.
Bloomfield, C. D.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Canc & Leukemia Grp B, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
10.1200/JCO.2007.25.18_SUPPL.7011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7011
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gene expression based outcome prediction in adult acute myeloid leukemia.
    Bullinger, L
    Dohner, K
    Bair, E
    Frohling, S
    Schlenk, R
    Tibshirani, R
    Dohner, H
    Pollack, JR
    BLOOD, 2003, 102 (11) : 370A - 370A
  • [22] Core Binding Factor Acute Myeloid Leukemia of the Elderly Treated with Conventional Chemotherapy : A Collaborative Study of the French CBF AML Intergroup
    Prebet, Thomas
    Boissel, Nicolas
    Recher, Christian
    Thomas, Xavier
    Delaunay, Jacques
    Cahn, Jean-Yves
    Pigneux, Arnaud
    Quesnel, Bruno
    Witz, Francis
    Thepot, Sylvain
    Ugo, Valerie
    Terre, Christine
    Tavernier, Emmanuelle
    Castaigne, Sylvie
    Guilhot, Francois
    Dombret, Herve
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 206 - 207
  • [23] Gene expression defined core binding factor acute myeloid leukemia subgroups
    Bullinger, L.
    Kurz, S.
    Doehner, K.
    Scholl, C.
    Ruecker, F. G.
    Froehling, S.
    Schlenk, R. F.
    Doehner, H.
    Pollack, R.
    ANNALS OF HEMATOLOGY, 2006, 85 : 13 - 13
  • [24] t(8;21) acute myeloid leukemia (AML) differs from inv(16) AML in pretreatment characteristics, outcome and prognostic factors predicting outcome:: A cancer and leukemia group B (CALGB) study.
    Marcucci, G
    Mrózek, K
    Ruppert, AS
    Maharry, K
    Kolitz, JE
    Mayer, RJ
    Pettenati, MJ
    Powell, BL
    Edwards, CG
    Sterling, LJ
    Vardiman, JW
    Schiffer, CA
    Carroll, AJ
    Larson, RA
    Bloomfield, CD
    BLOOD, 2004, 104 (11) : 556A - 556A
  • [25] Independent validation of prognostic relevance of a previously reported gene-expression signature in acute myeloid leukemia (AML) with normal cytogenetics (NC):: A cancer and leukemia group B (CALGB) study.
    Marcucci, G
    Radmacher, MD
    Ruppert, AS
    Mrózek, K
    Kolitz, JE
    Whitman, SP
    Edwards, CG
    Vardiman, JW
    Caligiuri, MA
    Carroll, AJ
    Larson, RA
    Bloomfield, CD
    BLOOD, 2005, 106 (11) : 223A - 223A
  • [26] Comprehensive mutational profiling of core binding factor acute myeloid leukemia
    Duployez, Nicolas
    Marceau-Renaut, Alice
    Boissel, Nicolas
    Petit, Arnaud
    Bucci, Maxime
    Geffroy, Sandrine
    Lapillonne, Helene
    Renneville, Aline
    Ragu, Christine
    Figeac, Martin
    Celli-Lebras, Karine
    Lacombe, Catherine
    Micol, Jean-Baptiste
    Abdel-Wahab, Omar
    Cornillet, Pascale
    Ifrah, Norbert
    Dombret, Herve
    Leverger, Guy
    Jourdan, Eric
    Preudhomme, Claude
    BLOOD, 2016, 127 (20) : 2451 - 2459
  • [27] Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Boddu, Prajwal
    Gurguis, Christopher
    Cortes, Jorge E.
    Akosile, Mary
    Ravandi, Farhad
    Sanford, David
    Brandt, Mark
    Maduike, Rita
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2017, 130
  • [28] Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Itzykson, Raphael
    Duployez, Nicolas
    Fasan, Annette
    Marceau-Renaut, Alice
    Meggendorfer, Manja
    Jourdan, Eric
    Petit, Arnaud
    Lapillonne, Helene
    Micol, Jean-Baptiste
    Cornillet-Lefebvre, Pascale
    Ifrah, Norbert
    Leverger, Guy
    Dombret, Herve
    Boissel, Nicolas
    Haferlach, Torsten
    Preudhomme, Claude
    BLOOD, 2017, 130
  • [29] Clinical Outcomes of Adults With Core Binding Factor Acute Myeloid Leukemia (CBF-AML): A Single Center Experience
    Chan, Kok Hoe
    Yohannan, Binoy
    Sridhar, Arthi
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S289 - S289
  • [30] Wilms tumor 1 (WT1) gene mutations predict poor outcome in adults with cytogenetically normal (CN) acute myeloid leukemia (AML): A cancer and leukemia group B (CALGB) study
    Paschka, Peter
    Marcucci, Guido
    Ruppert, Amy S.
    Mrozek, Krzysztof
    Whitman, Susan P.
    Maharry, Kati
    Langer, Christian
    Baldus, Claudia D.
    Powell, Bayard L.
    Baer, Maria R.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2007, 110 (11) : 113A - 114A
12345